Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users
Stroke 46:e167-e169, Baud, M.O.,et al, 2015
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015
Futile Interhospital Transfer for Endovascular Treatment in Acute Ischemic Stroke
Stroke 46:2156-2161, Fuentes, B.,et al, 2015
Mechanical Thrombectomy in Cerebral Venous Thrombosis
Stroke 46:1263-1268, Siddiqui, F.M.,et al, 2015
Safety of Intravenous Thrombolysis in Stroke Mimics
Stroke 46:1281-1287, Tsivgoulis, G.,et al, 2015
Prehospital Reversal of Warfarin-Related Coagulopathy in Intracerebral Hemorrhage in a Mobile Stroke Treatment Unit
Stroke 46:e118-e120, Gomes, J.A.,et al, 2015
Hyperbaric Oxygen Therapy for Acute Ischemic Stroke
Stroke 46:e109-e110, Bennett, M.H.,et al, 2015
Risk of Gastrointestinal Bleeding Associated with Oral Anticoagulants: Population Based Retrospective Cohort Study
BMJ 350:h1585, h1679, Chang, H.Y.,et al, 2015
Comparative Risk of Gastrointestinal Bleeding with Dabigatran, Rivaroxaban, and Warfarin: Population Based Cohort Study
BMJ 350:h1857, h1979, Abraham, N.S.,et al, 2015
Implementing a Mobile Stroke Unit Program in the United States
JAMA Neurol 72:229-234, Rajan, S.,et al, 2015
Effects of Golden Hour Thrombolysis
JAMA Neurol 72:25-30,9, Ebinger, M.,et al, 2015
Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients with Anticoagulation-Related Intracerebral Hemorrhage
JAMA 313:824-836, Kuramatsu, J.B.,et al, 2015
Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population
Stroke 45:3436-3439, Akoudad, S.,et al, 2014
Early Transfer of Patients with Stroke to Comprehensive Centers is Necessary
Stroke 45:3748-3749,3752, Sheth, K.N., 2014
Early Transfer of Patients with Stroke to Comprehensive Stroke Centers is not Necessary
Stroke 45:3750-3751,3752, Langhorne, P., 2014
New Microbleeds after Thrombolysis
Medicine 93:e99, Yan, S.,et al, 2014
Oral Anticoagulants and the Risk of Intracranial Hemorrhage
JAMA 312:2562-2563, Vespa, P.M., 2014
Hemodilution for Acute Ischemic Stroke
Stroke 46:e4-e5, Chang, T.S. & Jensen, M.B., 2014
Aggressive Medical Treatment with or without Stenting in High-Risk Patients with Intracranial Artery Stenosis (SAMMPRIS): The Final Results of a Randomised Trial
Lancet 383:33-341,290, Derdeyn, C.P.,et al, 2014
Evaluation of a Patient with Spinal Cord Infarction after a Hypotensive Episode
Stroke 45:e203-e205, Vongveeranonchai, N.,et al, 2014
Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014
Antiplatelet Therapy May be Continued after Intracerebral Hemorrhage
Stroke 45:3149-3150,3153, Salman, R.A. & Dennis, M.S., 2014
Aspirin Should be Discontinued after Lobar Intracerebral Hemorrhage
Stroke 45:3151-3152,3153, Falcone, G.J. & Rosand, J., 2014
Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014
Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014
Effect of Telestroke on Emergent Stroke Care and Stroke Outcomes
Stroke 45:1876-1880, Bladin, C.F. & Cadilhac, D.A., 2014
Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014
Reperfusion Therapies for Wake-Up Stroke
Stroke 45:1869-1875, Buck, D.,et al, 2014
Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014
Acute Basilar Artery Occlusion: Outcome of Mechanical Thrombectomy with Solitaire Stent within 8 Hours of Stroke Onset
AJNR 35:989-993, Baek, J.M.,et al, 2014
Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014
Six-Minute Magnetic Resonance Imaging Protocol for Evaluation of Acute Ischemic Stroke
Stroke 45:1985-1991, Nael, K.,et al, 2014
Incidence of Symptomatic Hemorrhage in Patients with Lobar Microbleeds
Stroke 45:2280-2285, Van Etten, E.S.,et al, 2014
Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis
Stroke 45:2469-2471, Geisbusch, C.,et al, 2014
Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated with Dabigatran or Warfarin
Stroke 45:2286-2291, Alonso, A.,et al, 2014
Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
Stroke 45:2372-2378, Giugliano, R.P.,et al, 2014
Aspirin for Acute Stroke of Unknown Etiology in Resourse-Limited Settings
Neurol 83:787-793, Berkowitz, A.L.,et al, 2014
Variation in Restarting Antithrombotic Drugs at Hospital Discharge after Intracerebral Hemorrhage
Stroke 45:2643-2648, Pasquini, M.,et al, 2014
Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014
Preadmission Oral Anticoagulant Treatment and Clinical Outcome Among Patients Hospitalized with Acute Stroke and Atrial Fibrillation
Stroke 45:168-175, Johnsen, S.P.,et al, 2014
Brush Sign on 3-T T2* - Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
Stroke 45:274-276, Terasawa, Y.,et al, 2014
Anticoagulants for Cerebral Venous Thrombosis
Stroke 45:298-304,8, Cundiff, D.K., 2014
Mystery Case: A 63-year-old Man with Progressive Proximal Pain and Weakness
Neurol 82:e26-e29, Scripko, P.D.,et al, 2014
Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014
Antithrombotic Medications and the Etiology of Intracerebral Hemorrhage
Neurol 82:529-535, Pezzini, A.,et al, 2014
Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014
4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014
The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial
Neurol 82:744-751, Marshall, R.S.,et al, 2014
Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials
Lancet 383:955-962,931, Ruff, C.T.,et al, 2014